ロード中...
Physician experiences and preferences in the treatment of HR+/HER2− metastatic breast cancer in the United States: a physician survey
Sequential endocrine therapy (ET) is recommended for postmenopausal women with hormone receptor‐positive (HR+)/human epidermal growth factor receptor 2‐negative (HER2−) metastatic breast cancer (mBC) and without visceral symptoms. Chemotherapy (CT) can be considered after sequential ETs, but is asso...
保存先:
| 出版年: | Cancer Med |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4735772/ https://ncbi.nlm.nih.gov/pubmed/26686532 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.580 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|